Sale of Empirical Bioscience, Inc. to Fortis Life Science, LLC
Based in Grand Rapids, MI, Empirical Bioscience Inc. (“Empirical Bioscience”) offers molecular biology solutions, including custom assay development, CDMO services, and the contract development of speciality enzymes. Its core offering includes: (i) the supply of custom enzymes and mastermix, (ii) manufacturing of proprietary enzymes, (iii) the supply of private label assay kits, and (iv) the supply CLIA laboratory reagents.
Its product library covers a wide range of molecular diagnostic technologies such as PCR, SNP Genotypoing, NGS Library Preparation and CRISPR and the Company has a broad base of innovative molecular diagnostic customers.
Pegasus Capital advised Empirical Bioscience on its sale to Fortis Life Sciences, LLC, a lifesciences tools business based in Waltham, MA and backed by Summit Partners, a leading global private equity firm.
Year: 2021
Sector: Healthcare
Terms: Not disclosed